Barbara S. Beckman - Publications

Affiliations: 
Tulane University, New Orleans, LA, United States 
Area:
Pharmacology, Cell Biology, Oncology

72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Hoang VT, Yan TJ, Cavanaugh JE, Flaherty PT, Beckman BS, Burow ME. MEK5-ERK5 Signaling in Cancer: Implications for Targeted Therapy. Cancer Letters. PMID 28153789 DOI: 10.1016/j.canlet.2017.01.034  0.72
2014 Gestaut MM, Antoon JW, Burow ME, Beckman BS. Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survival. Pharmacological Reports : Pr. 66: 174-8. PMID 24905325 DOI: 10.1016/j.pharep.2013.08.014  0.84
2014 Ponnapakam AP, Liu J, Bhinge KN, Drew BA, Wang TL, Antoon JW, Nguyen TT, Dupart PS, Wang Y, Zhao M, Liu YY, Foroozesh M, Beckman BS. 3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells. Bioorganic & Medicinal Chemistry. 22: 1412-20. PMID 24457089 DOI: 10.1016/j.bmc.2013.12.065  0.84
2014 Martin EC, Elliott S, Rhodes LV, Antoon JW, Fewell C, Zhu Y, Driver JL, Jodari-Karimi M, Taylor CW, Flemington EK, Beckman BS, Collins-Burow BM, Burow ME. Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells. Molecular Carcinogenesis. 53: 38-48. PMID 22911661 DOI: 10.1002/mc.21946  0.44
2013 White MD, Chan L, Antoon JW, Beckman BS. Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640. Anticancer Research. 33: 3573-9. PMID 24023282  0.44
2013 Antoon JW, Martin EC, Lai R, Salvo VA, Tang Y, Nitzchke AM, Elliott S, Nam SY, Xiong W, Rhodes LV, Collins-Burow B, David O, Wang G, Shan B, Beckman BS, et al. MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis. Plos One. 8: e69291. PMID 23950888 DOI: 10.1371/journal.pone.0069291  0.44
2013 Liu J, Beckman BS, Foroozesh M. A review of ceramide analogs as potential anticancer agents. Future Medicinal Chemistry. 5: 1405-21. PMID 23919551 DOI: 10.4155/fmc.13.107  0.68
2012 Antoon JW, White MD, Driver JL, Burow ME, Beckman BS. Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer. Experimental Biology and Medicine (Maywood, N.J.). 237: 832-44. PMID 22859737 DOI: 10.1258/ebm.2012.012028  0.44
2012 Antoon JW, Lai R, Struckhoff AP, Nitschke AM, Elliott S, Martin EC, Rhodes LV, Yoon NS, Salvo VA, Shan B, Beckman BS, Nephew KP, Burow ME. Altered death receptor signaling promotes epithelial-to-mesenchymal transition and acquired chemoresistance. Scientific Reports. 2: 539. PMID 22844580 DOI: 10.1038/srep00539  0.44
2012 Collins-Burow BM, Antoon JW, Frigo DE, Elliott S, Weldon CB, Boue SM, Beckman BS, Curiel TJ, Alam J, McLachlan JA, Burow ME. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. The Journal of Steroid Biochemistry and Molecular Biology. 132: 186-93. PMID 22634477 DOI: 10.1016/j.jsbmb.2012.05.004  0.44
2012 Bratton MR, Antoon JW, Duong BN, Frigo DE, Tilghman S, Collins-Burow BM, Elliott S, Tang Y, Melnik LI, Lai L, Alam J, Beckman BS, Hill SM, Rowan BG, McLachlan JA, et al. Gαo potentiates estrogen receptor α activity via the ERK signaling pathway. The Journal of Endocrinology. 214: 45-54. PMID 22562654 DOI: 10.1530/JOE-12-0097  0.44
2012 Antoon JW, White MD, Burow ME, Beckman BS. Dual inhibition of sphingosine kinase isoforms ablates TNF-induced drug resistance. Oncology Reports. 27: 1779-86. PMID 22469881 DOI: 10.3892/or.2012.1743  0.44
2012 Antoon JW, Beckman BS. Anti-proliferative effects of the novel ceramide analog (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide in chemoresistant cancer. Bioorganic & Medicinal Chemistry Letters. 22: 2624-8. PMID 22366655 DOI: 10.1016/j.bmcl.2012.01.087  0.84
2012 Walker CH, Drew BA, Antoon JW, Kalueff AV, Beckman BS. Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives. Cancer Investigation. 30: 135-48. PMID 22250588 DOI: 10.3109/07357907.2011.636116  0.44
2012 Drew BA, Burow ME, Beckman BS. MEK5/ERK5 pathway: the first fifteen years. Biochimica Et Biophysica Acta. 1825: 37-48. PMID 22020294 DOI: 10.1016/j.bbcan.2011.10.002  0.72
2011 Antoon JW, Meacham WD, Bratton MR, Slaughter EM, Rhodes LV, Ashe HB, Wiese TE, Burow ME, Beckman BS. Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer Journal of Molecular Endocrinology. 46: 205-216. PMID 21321095 DOI: 10.1530/JME-10-0116  0.44
2011 Antoon JW, Beckman BS. Sphingosine kinase: a promising cancer therapeutic target. Cancer Biology & Therapy. 11: 647-50. PMID 21307640  0.84
2011 Antoon JW, White MD, Slaughter EM, Driver JL, Khalili HS, Elliott S, Smith CD, Burow ME, Beckman BS. Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2. Cancer Biology & Therapy. 11: 678-89. PMID 21307639 DOI: 10.4161/cbt.11.7.14903  0.44
2011 Rhodes LV, Short SP, Neel NF, Salvo VA, Zhu Y, Elliott S, Wei Y, Yu D, Sun M, Muir SE, Fonseca JP, Bratton MR, Segar C, Tilghman SL, Sobolik-Delmaire T, ... ... Beckman BS, et al. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Research. 71: 603-13. PMID 21123450 DOI: 10.1158/0008-5472.CAN-10-3185  0.44
2010 Rhodes LV, Antoon JW, Muir SE, Elliott S, Beckman BS, Burow ME. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk. Molecular Cancer. 9: 295. PMID 21087507 DOI: 10.1186/1476-4598-9-295  0.84
2010 Antoon JW, White MD, Meacham WD, Slaughter EM, Muir SE, Elliott S, Rhodes LV, Ashe HB, Wiese TE, Smith CD, Burow ME, Beckman BS. Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640. Endocrinology. 151: 5124-35. PMID 20861237 DOI: 10.1210/en.2010-0420  0.44
2010 Bratton MR, Duong BN, Elliott S, Weldon CB, Beckman BS, McLachlan JA, Burow ME. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival. International Journal of Oncology. 37: 541-50. PMID 20664923 DOI: 10.3892/ijo-00000703  0.44
2010 Liu J, Antoon JW, Ponnapakkam A, Beckman BS, Foroozesh M. Novel anti-viability ceramide analogs: design, synthesis, and structure-activity relationship studies of substituted (S)-2-(benzylideneamino)-3-hydroxy-N-tetradecylpropanamides. Bioorganic & Medicinal Chemistry. 18: 5316-22. PMID 20639111 DOI: 10.1016/j.bmc.2010.05.044  0.84
2010 Struckhoff AP, Patel B, Beckman BS. Inhibition of p53 sensitizes MCF-7 cells to ceramide treatment. International Journal of Oncology. 37: 21-30. PMID 20514393  0.36
2010 Payton-Stewart F, Khupse RS, Boué SM, Elliott S, Zimmermann MC, Skripnikova EV, Ashe H, Tilghman SL, Beckman BS, Cleveland TE, McLachlan JA, Bhatnagar D, Wiese TE, Erhardt P, Burow ME. Glyceollin I enantiomers distinctly regulate ER-mediated gene expression. Steroids. 75: 870-8. PMID 20493896 DOI: 10.1016/j.steroids.2010.05.007  0.44
2010 Antoon JW, Liu J, Ponnapakkam AP, Gestaut MM, Foroozesh M, Beckman BS. Novel D: -erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics. Cancer Chemotherapy and Pharmacology. 65: 1191-5. PMID 20155475 DOI: 10.1007/s00280-009-1233-0  0.84
2010 Zimmermann MC, Tilghman SL, Boué SM, Salvo VA, Elliott S, Williams KY, Skripnikova EV, Ashe H, Payton-Stewart F, Vanhoy-Rhodes L, Fonseca JP, Corbitt C, Collins-Burow BM, Howell MH, Lacey M, ... ... Beckman BS, et al. Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy. The Journal of Pharmacology and Experimental Therapeutics. 332: 35-45. PMID 19797619 DOI: 10.1124/jpet.109.160382  0.44
2010 Rhodes LV, Muir SE, Elliott S, Guillot LM, Antoon JW, Penfornis P, Tilghman SL, Salvo VA, Fonseca JP, Lacey MR, Beckman BS, McLachlan JA, Rowan BG, Pochampally R, Burow ME. Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence. Breast Cancer Research and Treatment. 121: 293-300. PMID 19597705 DOI: 10.1007/s10549-009-0458-2  0.44
2009 Antoon JW, Liu J, Gestaut MM, Burow ME, Beckman BS, Foroozesh M. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells. Journal of Medicinal Chemistry. 52: 5748-52. PMID 19694470 DOI: 10.1021/jm9009668  0.84
2009 Meacham WD, Antoon JW, Burow ME, Struckhoff AP, Beckman BS. Sphingolipids as determinants of apoptosis and chemoresistance in the MCF-7 cell model system. Experimental Biology and Medicine (Maywood, N.J.). 234: 1253-63. PMID 19546354 DOI: 10.3181/0902-MR-77  0.84
2009 Rees BB, Figueroa YG, Wiese TE, Beckman BS, Schulte PM. A novel hypoxia-response element in the lactate dehydrogenase-B gene of the killifish Fundulus heteroclitus. Comparative Biochemistry and Physiology. Part a, Molecular & Integrative Physiology. 154: 70-7. PMID 19439190 DOI: 10.1016/j.cbpa.2009.05.001  0.44
2009 Boué SM, Tilghman SL, Elliott S, Zimmerman MC, Williams KY, Payton-Stewart F, Miraflor AP, Howell MH, Shih BY, Carter-Wientjes CH, Segar C, Beckman BS, Wiese TE, Cleveland TE, McLachlan JA, et al. Identification of the potent phytoestrogen glycinol in elicited soybean (Glycine max). Endocrinology. 150: 2446-53. PMID 19116342 DOI: 10.1210/en.2008-1235  0.44
2008 Zhou C, Nitschke AM, Xiong W, Zhang Q, Tang Y, Bloch M, Elliott S, Zhu Y, Bazzone L, Yu D, Weldon CB, Schiff R, McLachlan JA, Beckman BS, Wiese TE, et al. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Research : Bcr. 10: R105. PMID 19087274 DOI: 10.1186/bcr2210  0.72
2007 Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS, Burow ME. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression. International Journal of Oncology. 31: 705-11. PMID 17786300  0.72
2007 Abboud ER, Coffelt SB, Figueroa YG, Zwezdaryk KJ, Nelson AB, Sullivan DE, Morris CB, Tang Y, Beckman BS, Scandurro AB. Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells. International Journal of Oncology. 30: 113-22. PMID 17143519  0.44
2006 Salvo VA, Boué SM, Fonseca JP, Elliott S, Corbitt C, Collins-Burow BM, Curiel TJ, Srivastav SK, Shih BY, Carter-Wientjes C, Wood CE, Erhardt PW, Beckman BS, McLachlan JA, Cleveland TE, et al. Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 7159-64. PMID 17145841 DOI: 10.1158/1078-0432.CCR-06-1426  0.44
2006 Duong BN, Elliott S, Frigo DE, Melnik LI, Vanhoy L, Tomchuck S, Lebeau HP, David O, Beckman BS, Alam J, Bratton MR, McLachlan JA, Burow ME. AKT regulation of estrogen receptor beta transcriptional activity in breast cancer. Cancer Research. 66: 8373-81. PMID 16951146 DOI: 10.1158/0008-5472.CAN-05-3845  0.44
2005 Toews ML, Watts SW, Beckman BS. Preserving and promoting our discipline: pharmacology students speak out. Molecular Interventions. 5: 4-7. PMID 15731498 DOI: 10.1124/mi.5.1.1  0.44
2005 Weldon CB, McKee A, Collins-Burow BM, Melnik LI, Scandurro AB, McLachlan JA, Burow ME, Beckman BS. PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling. International Journal of Oncology. 26: 763-8. PMID 15703835  0.72
2005 Frigo DE, Vigh KA, Struckhoff AP, Elliott S, Beckman BS, Burow ME, McLachlan JA. Xenobiotic-induced TNF-alpha expression and apoptosis through the p38 MAPK signaling pathway. Toxicology Letters. 155: 227-38. PMID 15603917 DOI: 10.1016/j.toxlet.2004.09.008  0.44
2004 Williams CC, Allison JG, Vidal GA, Burow ME, Beckman BS, Marrero L, Jones FE. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. The Journal of Cell Biology. 167: 469-78. PMID 15534001 DOI: 10.1083/jcb.200403155  0.44
2004 Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. International Journal of Oncology. 24: 1473-80. PMID 15138590  0.44
2004 Struckhoff AP, Bittman R, Burow ME, Clejan S, Elliott S, Hammond T, Tang Y, Beckman BS. Novel ceramide analogs as potential chemotherapeutic agents in breast cancer. The Journal of Pharmacology and Experimental Therapeutics. 309: 523-32. PMID 14742741 DOI: 10.1124/jpet.103.062760  0.72
2004 Frigo DE, Tang Y, Beckman BS, Scandurro AB, Alam J, Burow ME, McLachlan JA. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway. Carcinogenesis. 25: 249-61. PMID 14604893 DOI: 10.1093/carcin/bgh009  0.44
2002 Figueroa YG, Chan AK, Ibrahim R, Tang Y, Burow ME, Alam J, Scandurro AB, Beckman BS. NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. Experimental Hematology. 30: 1419-27. PMID 12482504  0.72
2002 Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliott S, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME. Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery. 132: 293-301. PMID 12219026 DOI: 10.1067/msy.2002.125389  0.44
2001 Burow ME, Weldon CB, Tang Y, McLachlan JA, Beckman BS. Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. The Journal of Steroid Biochemistry and Molecular Biology. 78: 409-18. PMID 11738551 DOI: 10.1016/S0960-0760(01)00117-0  0.44
2001 Weldon CB, Burow ME, Rolfe KW, Clayton JL, Jaffe BM, Beckman BS. NF-κB-mediated chemoresistance in breast cancer cells Surgery. 130: 143-150. PMID 11490342 DOI: 10.1067/msy.2001.115512  0.44
2000 Burow ME, Weldon CB, Chiang TC, Tang Y, Collins-Burow BM, Rolfe K, Li S, McLachlan JA, Beckman BS. Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. International Journal of Oncology. 16: 1179-87. PMID 10811993  0.72
2000 Burow ME, Weldon CB, Melnik LI, Duong BN, Collins-Burow BM, Beckman BS, McLachlan JA. PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochemical and Biophysical Research Communications. 271: 342-5. PMID 10799299 DOI: 10.1006/bbrc.2000.2626  0.44
2000 Burow ME, Weldon CB, Collins-Burow BM, Ramsey N, McKee A, Klippel A, McLachlan JA, Clejan S, Beckman BS. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. The Journal of Biological Chemistry. 275: 9628-35. PMID 10734114  0.72
1999 Burow ME, Tang Y, Collins-Burow BM, Krajewski S, Reed JC, McLachlan JA, Beckman BS. Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells. Carcinogenesis. 20: 2057-61. PMID 10545406  0.72
1998 Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S, Beckman BS. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Research. 58: 4940-6. PMID 9810003  0.72
1997 Scandurro AB, Rondon IJ, Wilson RB, Tenenbaum SA, Garry RF, Beckman BS. Interaction of erythropoietin RNA binding protein with erythropoietin RNA requires an association with heat shock protein 70. Kidney International. 51: 579-84. PMID 9027743  0.44
1996 Klotz DM, Beckman BS, Hill SM, McLachlan JA, Walters MR, Arnold SF. Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays. Environmental Health Perspectives. 104: 1084-9. PMID 8930550  0.44
1996 Patterson KK, Beckman BS, Klotz DM, Mallia CM, Jeter JR. Dexniguldipine hydrochloride, a protein-kinase-C-specific inhibitor, affects the cell cycle, differentiation, P-glycoprotein levels, and nuclear protein phosphorylation in Friend erythroleukemia cells. Journal of Cancer Research and Clinical Oncology. 122: 465-75. PMID 8698746 DOI: 10.1007/BF01187158  0.44
1995 Mallia CM, Jeter JR, Fields AP, Wilson RB, Beckman BS. Protein kinase C beta from Friend erythroleukemia cells is associated with chromatin and DNA. Molecular and Cellular Biochemistry. 151: 107-11. PMID 8569755 DOI: 10.1007/BF01322332  0.44
1995 Mason-Garcia M, Harlan RE, Mallia C, Jeter JR, Steinberg HB, Fermin C, Beckman BS. Interleukin-3 or erythropoietin induced nuclear localization of protein kinase C beta isoforms in hematopoietic target cells. Cell Proliferation. 28: 145-55. PMID 7734624 DOI: 10.1111/j.1365-2184.1995.tb00063.x  0.44
1995 Gogu SR, Beckman BS, Wilson RB, Agrawal KC. Inhibitory effects of zidovudine in erythroid progenitor cells. Reversal with a combination of erythropoietin and interleukin-3. Biochemical Pharmacology. 50: 413-9. PMID 7646543 DOI: 10.1016/0006-2952(95)00134-L  0.44
1994 Maness LM, Kastin AJ, Weber JT, Banks WA, Beckman BS, Zadina JE. The neurotrophins and their receptors: structure, function, and neuropathology. Neuroscience and Biobehavioral Reviews. 18: 143-59. PMID 8170621 DOI: 10.1016/0149-7634(94)90043-4  0.44
1993 Silliman CC, Beckman BS, Jeter JR. Changes in protein kinase activity within 30 min of induced differentiation in Friend erythroleukemia cells. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 71: 1-6. PMID 8392352  0.44
1993 Nakashima J, Ohigashi T, Brookins JW, Beckman BS, Agrawal KC, Fisher JW. Effects of 5'-N-ethylcarboxamideadenosine (NECA) on erythropoietin production. Kidney International. 44: 734-40. PMID 8258950  0.44
1992 Gogu SR, Beckman BS, Agrawal KC. Amelioration of zidovudine-induced fetal toxicity in pregnant mice. Antimicrobial Agents and Chemotherapy. 36: 2370-4. PMID 1489179  0.44
1991 Rondon IJ, MacMillan LA, Beckman BS, Goldberg MA, Schneider T, Franklin Bunn H, Malter JS. Hypoxia up-regulates the activity of a novel erythropoietin mRNA binding protein Journal of Biological Chemistry. 266: 16594-16598. PMID 1653242  0.44
1990 Mason-Garcia M, Beckman BS, Brookins JW, Powell JS, Lanham W, Blaisdell S, Keay L, Li SC, Fisher JW. Development of a new radioimmunoassay for erythropoietin using recombinant erythropoietin Kidney International. 38: 969-975. PMID 2266682  0.44
1990 Beckman BS, Mason-Garcia M, Martinez MI, Fermin C. Enhanced expression of the β II subspecies of protein kinase C in differentiating erythroleukemia cells Experimental Cell Research. 191: 319-322. PMID 2257884 DOI: 10.1016/0014-4827(90)90021-2  0.44
1990 Beckman BS, Jeter JR. 15-Lipoxygenase products affect protein phosphorylation in Friend erythroleukemia cells. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 68: 1052-6. PMID 2223013  0.44
1990 Pincus SM, Beckman BS, Broadway RL, George WJ, Jeter JR. Early changes in phosphoprotein patterns of Friend erythroleukaemia cells induced by dimethylsulphoxide or phorbol esters. Cytobios. 64: 23-33. PMID 1963392  0.44
1989 Gogu SR, Beckman BS, Agrawal KC. Anti-HIV drugs: comparative toxicities in murine fetal liver and bone marrow erythroid progenitor cells. Life Sciences. 45: iii-vii. PMID 2761343 DOI: 10.1016/0024-3205(89)90135-5  0.44
1989 Beckman BS, Brookins JW, Garcia MM, Fisher JW. Measurement of erythropoietin in anephric children - A report of the Southwest Pediatric Nephrology Study Group Pediatric Nephrology. 3: 75-79. PMID 2702091 DOI: 10.1007/BF00859630  0.44
1989 Gogu SR, Beckman BS, Rangan SR, Agrawal KC. Increased therapeutic efficacy of zidovudine in combination with vitamin E. Biochemical and Biophysical Research Communications. 165: 401-7. PMID 2590237 DOI: 10.1016/0006-291X(89)91084-X  0.44
1987 Beckman BS, Kopfler W, Koury P, Jeter JR. Effect of aphidicolin on Friend erythroleukemia cell maturation. Experimental Cell Research. 169: 223-32. PMID 3102267 DOI: 10.1016/0014-4827(87)90240-0  0.44
Show low-probability matches.